EW vs PGC · P/E 47, rev $1.39B vs P/E 18, rev $228.1M
Edwards Lifesciences Corp (EW) versus Peapack-Gladstone Financial (PGC) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Peapack-Gladstone Financial (PGC) is a banks - regional company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PGC revenue for 2024-12-31 was $228.1M. Net income was $33.0M. Revenue was down 0.7% from 2023-12-31 to 2024-12-31. PGC currently screens at market cap $778.9M and trailing P/E 17.8.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PGC currently screens at market cap $778.9M and trailing P/E 17.8.
Not investment advice. Open the EW and PGC stock pages for the full models.
Not investment advice.